WebJan 15, 2015 · Phosphoantigens are molecules with a very small mass and only stimulate Vγ9Vδ2 cells in the presence of antigen-presenting cells, suggesting a strict requirement … WebNon-peptidic antigens are low-molecular-weight compounds that stimulate human Vγ9/Vδ2 T cells. The most potent activator for Vγ9/Vδ2 T cells is ( E )-4-hydroxy-3-methyl …

Sensing of Pyrophosphate Metabolites by Vγ9Vδ2 T Cells

WebAug 14, 2014 · Phosphoantigens such as HMBPP are detected by the Vγ9Vδ2 T cell receptor after binding to butyrophilin 3A1 (BTN3A1) ( Harly et al., 2012, Wang et al., 2013) through major histocompatibility complex-independent mechanisms that … WebAlthough human Vδ1, Vδ2, and Vδ3 T-cells show a strong reactivity against tumor cells, γδ T-cell-based immunotherapies primarily target the Vδ2 subset, because they can be easily expanded and specifically activated with synthetic clinical-grade phosphoantigens (e.g., BrHPP), or with pharmacological inhibitors of the mevalonate pathway (e ... on trill

Butyrophilin 2A1 is essential for phosphoantigen

WebMar 15, 2024 · These are known as phosphoantigens, byproducts of the Mtb mevalonate metabolic pathway. The smaller periphery-bound subset of Vδ1 T cells bind to antigens displayed by several subtypes of MHC-I-like molecules, i.e., MHC-I chain-related gene A (MICA), via the NKG2D receptor shared also with CD8 + and NK cells, CD1, and endothelial … WebThese results suggest BTN3A1 selectively detects P–Ag intracellularly via a conformational antigenic sensor in its B30.2 domain and have implications for rational design of antigens for Vγ9/Vδ2-based T-cell immunotherapies. Supporting Information WebPhosphoantigens stimulate Vγ9Vδ2 T cells after binding to BTN3A1 in target cells and cell-cell contact. We evaluated phosphoantigens including diphosphates, bisphosphonates, and prodrugs for ability to induce leukemia cells to stimulate Vγ9Vδ2 T cell interferon-γ … iot based smart bottle for healthcare